Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccine 195

World of DTC Marketing

FEBRUARY 7, 2022

According to Endpoint News” We’ve seen Biogen’s CSO exit under pressure in recent weeks, and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Finally, they need to withdraw Aduhelm from the market.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

Bio Pharma Dive

AUGUST 11, 2023

In Europe, however, the biotech is appealing a negative decision from regulators that has for now blocked its path to market there.

Sales 130

Sales Regulation Drugs Marketing 130

World of DTC Marketing

OCTOBER 5, 2021

last year gave away more than $23 billion in rebates to insurance intermediaries, but still netted $50 billion in sales. sales of the 20 top-selling drugs worldwide totaled $101.1 billion while sales to the rest of the world totaled nearly $57 billion. sales of the 20 top-selling drugs worldwide totaled $101.1

Sales 241

Sales Drugs Manufacturing Production 241

pharmaphorum

OCTOBER 11, 2022

An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy? ” The post Wellcome funds work on regulating digital mental health tools appeared first on. . The healthcare charity is providing £1.8

Regulation 122

Regulation Production Development Sales 122

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical companies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health. No product is mentioned for help-seeking advertising.

Marketing 130

Marketing Compliance Production Doctors 130

Pharma Marketing Network

MARCH 17, 2025

With increasing competition and stricter compliance regulations, pharma marketing teams must adopt data-driven and personalized marketing strategies to capture the attention of HCPs. But how can pharma brands stand out in a crowded market? For expert guidance on pharma marketing trends, visit Pharma Marketing Network.

Branding 52

Branding Marketing Compliance Pharma Companies 52

Pharma Marketing Network

DECEMBER 31, 2024

Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat.

Marketing 52

Marketing Branding Compliance Drugs 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Other reasons include lower sales demand and high investment costs.

Marketing 130

Marketing Sales Manufacturing Drugs 130

Pharmaceutical Technology

DECEMBER 8, 2022

According to the revised deal, Daiichi Sankyo and Kite will transfer the Marketing Authorization for Yescarta to Gilead’s Japan subsidiary, Gilead Sciences K.K., The therapy’s sales and promotion works in Japan following the transfer of marketing authorisation will be carried out by the Kite Cell Therapy Business Unit at Gilead Sciences K.K.

Licensing 305

Licensing Licensing Gene Therapy Gene 305

Pharma in Brief

AUGUST 9, 2021

On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. Health Canada is accepting comments on the Minister of Health’s proposal to amend the FDR and the Medical Devices Regulations until October 28, 2021.

Regulation 98

Regulation Drugs Manufacturing Production 98

pharmaphorum

JULY 29, 2021

billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but making it available at no profit had weighed on its profit margins. A delayed FDA filing – held up by data requests from the US regulator – should take place before the end of the year, according to the CEO. billion from its one-dose vaccine.

Sales 98

Sales Vaccine Vaccination Regulation 98

pharmaphorum

DECEMBER 28, 2022

Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process.

Sales 98

Sales Doctors Doctor Production 98

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region.

Marketing 109

Marketing Regulation Production Medicine 109

pharmaphorum

AUGUST 8, 2022

As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Marketing 111

Marketing Sales Gene Editing Antibody 111

pharmaphorum

APRIL 30, 2021

It’s fair to say this is the most interesting time ever for market access. A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how they can find a smoother path to market. Time for a NICE change. How will NICE fare in a post-Brexit world?

Marketing 98

Marketing Sales Regulation Drugs 98

Pharmaceutical Technology

JANUARY 31, 2023

Under the terms of the deal, uniQure will obtain the worldwide rights to develop and market the clinical stage gene therapy, APB-102. The regulator has also cleared the investigational new drug (IND) application for APB-102. uniQure will also provide tiered royalties ranging from mid-single digits to low double digits on the net sales.

Gene Therapy 277

Gene Therapy Licensing Licensing Gene 277

Pharma Marketing Network

JULY 12, 2023

The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. They are individuals with unique needs, concerns, and experiences.

Marketing 98

Marketing Compliance Regulation Branding 98

pharmaphorum

AUGUST 10, 2021

Europe market has proved so hostile to gene therapies when it comes to pricing and reimbursement for gene therapies that bluebird bio has decided to quit the market altogether, according to Andrew Obenshain, president of its severe genetic diseases unit. market and will wind down in Europe. market and will wind down in Europe.

Gene Therapy 135

Gene Therapy Gene Marketing Genetic Disease 135

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. With medical staff working tirelessly and lockdown restrictions in place across the world, the way pharma markets medications has changed, too.

Marketing 100

Marketing Doctors Doctor Pharma Companies 100

XTalks

JULY 7, 2023

Earlier this week, the World Health Organization (WHO) released new guidelines that emphasized the critical role that marketers must play in safeguarding children’s health. The WHO underscored the need for tighter regulations to protect children from the adverse effects of food marketing.

Marketing 97

Marketing Production Regulation Branding 97

XTalks

JUNE 3, 2024

The market for hemp beverages has been growing rapidly in recent years. The passing of the 2018 Farm Bill, which legalized hemp production, boosted the market, allowing companies to explore hemp as a primary ingredient. Its branding and marketing strategies have resonated well with younger, health-conscious consumers.

Regulation 52

Regulation Marketing Production Protein 52

BioPharma Reporter

AUGUST 1, 2022

GSKâs first quarter following the demerger of its consumer health business sees the company raise its 2022 sales guidance to between 6-8%, up from 5-7% on its previous estimation.

Sales 98

Sales Regulation Marketing 98

Pharma Marketing Network

OCTOBER 14, 2023

In this article, we will explore the challenges of balancing privacy concerns with targeted ads in pharma marketing. In many countries, there are laws in place that regulate the use of personal data. This can help companies reach more potential customers and increase their sales.

Marketing 97

Marketing Sales Compliance Production 97

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 130

Branding Marketing Pharma Companies Life Science 130

pharmaphorum

NOVEMBER 22, 2022

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market. Sales have been modest to date – just £36 million in the third quarter – despite it being the first drug targeting BCMA to reach the market.

Marketing 105

Marketing Trials Antibody Clinical Trials 105

Pharmaceutical Technology

SEPTEMBER 15, 2022

Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. Finding the best commercial packaging suppliers in contract marketing. Finding the best commercial packaging suppliers in contract marketing.

Packaging 100

Packaging Packaging Marketing Containment 100

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Capturing market share. Better customer experience. billion in 2021 to $9.23

Marketing 98

Marketing Life Science Sales Branding 98

STAT News

MARCH 10, 2023

Now, as federal regulators step in to clean up SVB’s mess, biotech startups are left wondering: What happens to their money, and who’s going to finance the industry? Silicon Valley Bank, which does business with roughly half of the nation’s tech and biotech companies, failed on Friday.

Sales 145

Sales Regulation Marketing 145

Pharmaceutical Technology

JUNE 21, 2023

Ketarx will be marketed under the FDA-approved label of ketamine and in dosages that include 10mg/ml, 50mg/ml and 100mg/ml, with the option to boost the concentration and ready-to-administer applications. PharmaTher and Vitruvias Therapeutics have entered a collaboration deal to commercialise PharmaTher’s Ketarx (racemic ketamine) in the US.

FDA Approval 130

FDA Approval Sales Marketing Regulation 130

BioPharma Reporter

APRIL 25, 2024

Back in 2014, AstraZeneca and Merck were the first to receive FDA approval for their PARP inhibitor Lynparza (olaparib) for use in breast cancer gene (BRCA)-mutated metastatic ovarian cancer patients.

FDA Approval 98

FDA Approval Sales Gene Marketing 98

FDA Law Blog

AUGUST 15, 2021

Shapiro — A determination of “intended use” is fundamental to FDA’s regulation of drugs and medical devices. It is a primary basis for determining if an article is regulated by FDA at all, and if so, what regulatory requirements apply. Thus ends a saga that began with a proposal in 2015 to amend the “intended use” regulation.

Regulation 93

Regulation Manufacturing Drugs Marketing 93

World of DTC Marketing

MARCH 24, 2022

He came from the salesforce, and his mentality was simple; marketing supports sales. Most of us agree that the industry tends to be over-regulated, but I’ve never seen anyone say, “the hell with legal and regulatory review, let’s do it.” John worked for a division of a major pharma company in Cambridge.

Pharma Companies 213

Pharma Companies HR Sales Regulation 213

pharmaphorum

FEBRUARY 16, 2021

COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. . The R&D focus began to shift, and so did the marketing.

Marketing 106

Marketing Production Big Data Pharma Companies 106

XTalks

MARCH 1, 2021

Anti-inflammatory drugs like Restasis and Xiidra are popular treatment options for the condition, but will the emergence of mask-associated dry eye bolster their sales? But if you thought the growing number of patients presenting with mask-associated dry eye would mean higher sales for Restasis, think again.

Sales 119

Sales Drugs Life Science Containment 119

BioPharma Reporter

FEBRUARY 2, 2023

Pfizer expects to see a 64% drop in Comirnaty revenues this year, which will hit its 2023 revenue guidance.

Sales 105

Sales Production Marketing Regulation 105

Outsourcing Pharma

SEPTEMBER 8, 2023

has seen sales grow by triple digits and has received more than 100 orders since its launch in March 2022. A benchtop DNA sequencer developed by the U.S. DNA sequencing company Element Biosciences, Inc.,

DNA 84

DNA Sales Development Regulation 84